menu toggle
Contact Us
About us
Who we are
Our global reach
Gallery of innovation
Expertise
Why Xcenda?
Areas of expertise
Solutions
Commercialization solutions
Innovative field solutions
Health economics & outcomes research
Reimbursement & policy insights
Real-world evidence
FormularyDecisions
Value and access communications
Global market access consulting
Product launch and commercialization
Market research and advisor networks
Training & learning solutions
Manufacturer solutions from AmerisourceBergen
Our people
Our team
Insights
Insights home
Health Policy Weekly archive
HTA Quarterly archive
Careers
Careers
Life at Xcenda
Student programs
Search for jobs
The AmerisourceBergen network
News and events
Locations
Subscribe to newsletters
Contact us
LinkedIn
X
Instagram
About us
Who we are
Our global reach
Gallery of innovation
Expertise
Why Xcenda?
Areas of expertise
Solutions
Commercialization solutions
Innovative field solutions
Health economics & outcomes research
Reimbursement & policy insights
Real-world evidence
FormularyDecisions
Value and access communications
Global market access consulting
Product launch and commercialization
Market research and advisor networks
Training & learning solutions
Manufacturer solutions from AmerisourceBergen
Our people
Our team
Insights
Insights home
Health Policy Weekly archive
HTA Quarterly archive
Careers
Careers
Life at Xcenda
Student programs
Search for jobs
The AmerisourceBergen network
News and events
Locations
Subscribe to newsletters
Contact us
LinkedIn
X
Instagram
Insights
Filter By
All Topics
340B
Advocacy
Affordability
Analytics
Biosimilars
Business performance
Cell and gene therapy
Clinical trial logistics
Commercial supply chain
Commercialization
Consulting
COVID-19
Data
Direct-to-patient
Distribution
Engagement
Field Support
Financial management
Formulary solutions
Health equity
Innovation
Legislation
Managed care
Market access
Marketing
Medication adherence
Medication therapy management
Oncology
Orphan drugs
Our role in healthcare
Patient care
Patient support services
Policy
Population health management
Product access
Quality
Regulatory
Reimbursement
Research
Specialty pharmacy
Technology
Value-based care
Sort By
Date (Newest to Oldest)
Date (Oldest to Newest)
Title (A-Z)
Title (Z-A)
Filter
Xcenda
Issue Brief: Assessing the impact of formulary exclusion on healthcare costs and outcomes for patients on therapy for certain chronic conditions
Xcenda
May 2023
Medicare cannot age in place: A diversifying population requires policy evolution
Xcenda
March 2023
Telehealth through the lens of value-based care in the US
Xcenda
November 2021
ASCVD needs innovation
Xcenda
November 2021
Affordability is about more than drug prices
Xcenda
July 2021
Copay accumulators and the impact on patients
Corey Ford, MHA
June 2021
Update: The impact of obesity on COVID-19 outcomes of hospitalizations and mortality
Xcenda
June 2021
The impact of obesity on COVID-19 outcomes of hospitalizations and mortality
Xcenda
January 2021
It’s the Healthcare of the Future: Telehealth Trends Beyond 2020
Xcenda
November 2020
Patient-Centered Cost Outcomes—Addressing a Gap in Value Assessment
Xcenda
November 2020
Webinar | Navigating COVID-19: Simplifying the Path to Better Patient Outcomes
Tommy Bramley, PhD; Corey Ford, MHA
Lash Group
August 2020
The Heart of the Value Story
Xcenda
June 2020
